Verano Holdings VRNO
OTC VRNO
$6.21 +0.16 (+2.64%)
As of: Aug 21, 2026 · 3:59 PM EDT

Verano Holdings (VRNO) Depreciation & Amortization (CF) (2021 - 2026)

Verano Holdings (VRNO) posted quarterly Depreciation & Amortization (CF) of $29.2 million for Q1 2026, down 8.19% year-over-year from $31.8 million in Q1 2025, and little changed quarter-over-quarter from $29.3 million in Q4 2025.

Verano Holdings (VRNO) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has reported Depreciation & Amortization (CF) for 6 consecutive years, with $29.2 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Depreciation & Amortization (CF) fell 8.19% year-over-year to $29.2 million; the TTM figure through Mar 2026 stood at $121.6 million (down 10.56% YoY), while the FY2025 annual figure was $124.2 million, down 11.1% from the prior year.
  • Depreciation & Amortization (CF) steadied at $29.2 million in Q1 2026 per VRNO's latest filing, from $29.3 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $36.9 million in Q3 2024 and bottomed at $29.2 million in Q1 2026.
  • Historically, Depreciation & Amortization (CF) has averaged $33.9 million across 5 years, with a median of $35.2 million in 2022.
  • Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 46.15% — and 2025, when it slipped 14.39%.
  • Verano Holdings' Depreciation & Amortization (CF) stood at $35.2 million in 2022, then advanced by 1.19% to $35.6 million in 2023, then retreated by 11.41% to $31.5 million in 2024, then declined by 6.97% to $29.3 million in 2025, then retreated by 0.44% to $29.2 million in 2026.
  • Business Quant data shows VRNO's Depreciation & Amortization (CF) at $29.2 million in Q1 2026, $29.3 million in Q4 2025, and $31.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 241.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 119.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 1.02 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 24.20 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 672.30 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 171.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Verano Holdings 449.04 Mn 363.85 Mn 99.70 Mn 29.43 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 29.43 Mn
Jun 30, 2026 29.43 Mn
Mar 31, 2026 29.19 Mn
Mar 31, 2026 29.19 Mn
Dec 31, 2025 29.32 Mn
Dec 31, 2025 29.32 Mn
Sep 30, 2025 31.56 Mn
Sep 30, 2025 31.56 Mn
Jun 30, 2025 31.49 Mn
Jun 30, 2025 31.49 Mn
Mar 31, 2025 31.79 Mn
Mar 31, 2025 31.79 Mn
Dec 31, 2024 31.51 Mn
Dec 31, 2024 31.51 Mn
Sep 30, 2024 36.87 Mn
Sep 30, 2024 36.87 Mn
Jun 30, 2024 35.73 Mn
Jun 30, 2024 35.73 Mn
Mar 31, 2024 35.55 Mn
Mar 31, 2024 35.55 Mn